Tryp Therapeutics Inc (TRYP.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
(Values in thousands)
| 05-2021 | 02-2021 | 11-2020 | |
| Operating Expenses | 2,576 | 1,437 | 523 |
| Operating Income | -2,576 | -1,437 | -523 |
| Interest Expense | N/A | 3 | N/A |
| Other Income | 4 | -950 | 0 |
| Pre-tax Income | -2,571 | -2,390 | -523 |
| Net Income Continuous | -2,571 | -2,390 | -523 |
| Net Income | $-2,571 | $-2,390 | $-523 |
| EPS Basic Total Ops | -0.04 | -0.05 | -0.01 |
| EPS Basic Continuous Ops | -0.04 | -0.05 | N/A |
| EPS Diluted Total Ops | -0.04 | -0.05 | -0.01 |
| EPS Diluted Continuous Ops | -0.04 | -0.05 | N/A |
| EBITDA(a) | $-2,576 | $-2,387 | $-523 |